Related Experiment Video

Updated: Aug 20, 2026

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
15:43

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Published on: March 17, 2014

Pseudomonas invasion of type I pneumocytes is dependent on the expression and phosphorylation of caveolin-2

David W Zaas1, Mathew J Duncan, Guojie Li

  • 1Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine Duke University Medical Center, Durham, North Carolina 27710, USA

The Journal of Biological Chemistry
|November 17, 2004
PubMed

Insights

Pseudomonas aeruginosa invades lung cells using a lipid raft mechanism. Disrupting these rafts or caveolin-2 impairs bacterial entry, offering potential therapeutic targets for pneumonia.

Area of Science:

  • Cell Biology
  • Microbiology
  • Infectious Diseases

Background:

  • Pseudomonas aeruginosa is a significant pathogen causing pneumonia, particularly in immunocompromised individuals and cystic fibrosis patients.
  • Bacterial invasion of host cells is a critical step in pathogenesis, but the mechanisms for Pseudomonas aeruginosa entry into lung epithelial cells are not fully understood.

Purpose of the Study:

  • To investigate the mechanism by which Pseudomonas aeruginosa invades type I pneumocytes.
  • To determine the role of lipid rafts and associated proteins in this invasion process.

Main Methods:

  • Utilized rat primary type I-like pneumocytes and a murine lung epithelial cell line (MLE-12).
  • Employed cholesterol-depleting drugs and lipid raft disruptors to assess invasion inhibition.
  • Performed confocal microscopy to visualize co-localization of bacteria with lipid raft components.
  • Generated caveolin-1 and -2 knockdowns using RNA interference techniques.

Main Results:

  • P. aeruginosa invasion was inhibited by agents that disrupt lipid rafts and deplete membrane cholesterol.
  • Intracellular bacteria co-localized with lipid raft components, including caveolin-1 and -2.
  • Reduced caveolin-2 expression significantly impaired P. aeruginosa invasion.
  • Lipid raft-dependent tyrosine phosphorylation of caveolin-2 was identified as a critical regulator of invasion.

Conclusions:

  • Pseudomonas aeruginosa invades type I pneumocytes through a lipid raft-mediated mechanism.
  • Caveolin-2 plays a crucial role in P. aeruginosa entry into lung epithelial cells.
  • Targeting lipid rafts and caveolin-2 represents a potential therapeutic strategy against P. aeruginosa pneumonia.

More Related Videos

Studying Effects of Cigarette Smoke on Pseudomonas Infection in Lung Epithelial Cells09:15

Studying Effects of Cigarette Smoke on Pseudomonas Infection in Lung Epithelial Cells

Published on: May 11, 2020

In vitro Coculture Assay to Assess Pathogen Induced Neutrophil Trans-epithelial Migration14:14

In vitro Coculture Assay to Assess Pathogen Induced Neutrophil Trans-epithelial Migration

Published on: January 6, 2014

Related Concept Videos

IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and produces two-second...
Regulation of Bacterial Virulence01:28

Regulation of Bacterial Virulence

Pathogenic bacteria employ a range of regulatory mechanisms to modulate the expression of virulence genes in response to environmental and host-derived signals. These mechanisms ensure that virulence factors are expressed only under favorable conditions, thereby optimizing infection and survival strategies.Mechanisms of Virulence RegulationKey regulatory strategies include:Two-Component Systems: These consist of a membrane-bound sensor kinase and a cytoplasmic response regulator. Environmental...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...